openPR Logo
Press release

Insulin Delivery devices Market Report, Size, Share & Outlook - 2024-2031 - Becton Dickinson, Novo nordisk & GlaxoSmithKline.

09-09-2024 08:41 AM CET | Chemicals & Materials

Press release from: DataM Intelligence 4market Research LLP

Insulin Delivery devices Market || 2024-2031

Insulin Delivery devices Market || 2024-2031

The global Insulin Delivery devices Market is projected to grow at a CAGR of 5.3% from 2024 to 2031.

Diabetes is a condition characterized by elevated blood glucose levels due to the body's inability to properly regulate insulin, a hormone crucial for converting glucose into energy. In Type 1 diabetes, the body does not produce insulin, necessitating the use of insulin delivery devices to administer insulin from external sources into the bloodstream. Common methods for insulin delivery include syringes, insulin pumps, sprays, and insulin pens, each designed to help manage blood glucose levels effectively and maintain metabolic balance.

Get a Free Sample Research PDF - https://www.datamintelligence.com/download-sample/insulin-delivery-devices-market

Market Trends:

Diabetes mellitus is a critical global health issue with profound impacts on individuals, families, and national economies. According to the International Diabetes Federation (IDF) Diabetes Atlas, approximately 537 million adults aged 20 to 79 had diabetes in 2021, representing about one in ten people worldwide. This number is projected to increase to 643 million by 2030, with significant prevalence in Europe and North America. Uncontrolled diabetes can lead to severe health complications, including reduced quality of life and increased morbidity and mortality. This rising incidence drives the demand for effective insulin delivery devices to better manage the condition and mitigate associated risks.

Despite advancements, subcutaneous insulin administration poses challenges such as injection pain, inconvenience, and inconsistent compliance. Additionally, it can lead to peripheral hyperinsulinemia, differing from the natural insulin distribution to the portal vein. These drawbacks may impede the market growth for insulin delivery devices, as patients and healthcare providers seek more effective and comfortable management solutions.

Market Segmentation:

By Product Type: Syringes, Insulin Pens, and dosers, Infusion pumps, Oral insulin, Insulin sprays, Insulin patches, Jet injectors, Automated insulin delivery system.

Get Customization Report: https://www.datamintelligence.com/customize/insulin-delivery-devices-market

Major Players:

• Becton Dickinson
• Eli Lilly and Company
• Merck & Co.
• Novo nordisk
• GlaxoSmithKline
• Bristol-Myers Squibb
• Astrazeneca
• Sanofi
• Roche Holding AG
• Amgen
• Johnson & Johnson
• Abbott laboratories
• Tandem diabetes care

Product Portfolio:

Novo Nordisk is a Danish multinational pharmaceutical company and a full member of the European Federation of Pharmaceutical Industries and Associations. Specializing in diabetic medications and devices, Novo Nordisk also offers products and services related to hemostasis management, growth hormone therapy, and hormone replacement therapy. The company produces a range of drugs under various brand names, such as Levemir, Tresiba, NovoLog, Novolin R, NovoSeven, NovoEight, and Victoza. Novo Nordisk markets its products in over 165 countries globally.

Regional Analysis:

The global Insulin Delivery devices Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Insulin Delivery devices Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Related Reports:

Microneedles Drug Delivery Market: https://datamintelligence.com/research-report/microneedles-drug-delivery-market

Transdermal Drug Delivery Devices Market: https://datamintelligence.com/research-report/transdermal-drug-delivery-devices-market

Affiliate Marketing Request here: https://www.datamintelligence.com/affiliate-marketing

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Insulin Delivery devices Market Report, Size, Share & Outlook - 2024-2031 - Becton Dickinson, Novo nordisk & GlaxoSmithKline. here

News-ID: 3649002 • Views:

More Releases from DataM Intelligence 4market Research LLP

U.S. Lung Cancer Surgery Market Grows as Robotic & Minimally Invasive Techniques Transform Care
U.S. Lung Cancer Surgery Market Grows as Robotic & Minimally Invasive Techniques …
Leander, Texas, United States - Dec.17.2025 As per DataM Intelligence research report "Global Lung Cancer Surgery Market is growing with a high 3.6 % CAGR from 2024 to 2031."Growing prevalence of lung cancer, rising air pollution, increasing smoking rates, and advancements in minimally invasive and robotic-assisted surgical techniques are driving the lung cancer surgery market. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/lung-cancer-surgery-market?sindhuri Lung Cancer Surgery Market: Recent Industry
United States Facility Management Robotics Market Strengthens Every Ounce at 7.67% CAGR - $6.55 Billion Milestone by 2032, Led by Avidbots Corp and Tennant Company as Top Competitors | DataM Intelligence
United States Facility Management Robotics Market Strengthens Every Ounce at 7.6 …
Leander, Texas and TOKYO, Japan - Dec. 17, 2025. According to DataM Intelligence, the United States Facility Management Robotics Market Size reached USD 3,659 million in 2024 and is projected to reach USD 6,553 million by 2032, registering a robust CAGR of 7.67% during 2025-2032. The surging demand for automated cleaning and security solutions, persistent labor shortages across commercial sectors, and advancements in AI-driven navigation and sensor technologies are fueling
United States Appendix Cancer Drugs Market Advances as Targeted Therapies, Drug Repurposing & Precision Oncology Accelerate
United States Appendix Cancer Drugs Market Advances as Targeted Therapies, Drug …
Leander, Texas, United States - Dec.17.2025 As per DataM Intelligence research report Rising prevalence of appendix cancer, advancements in targeted therapies, and increasing R&D initiatives are driving the development of innovative drugs for appendix cancer treatment. Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/appendix-cancer-drugs-market?sindhuri Appendix Cancer Drugs Market: Recent Industry Developments United States: Recent Industry Developments ✅ In November 2025, Pfizer Inc. advanced its oncology pipeline with expanded research into targeted
United States Hospitality Service Robots Market Strengthens Every Ounce at 12.7% CAGR - $3.25 Billion Milestone by 2032, Led by Bear Robotics, Inc. and LG Electronics as Top Competitors | DataM Intelligence
United States Hospitality Service Robots Market Strengthens Every Ounce at 12.7% …
Leander, Texas and TOKYO, Japan - Dec. 17, 2025. According to DataM Intelligence, the United States Hospitality Service Robots Market Size reached USD 1,260 million in 2024 and is expected to reach USD 3,252 million by 2032, registering a robust CAGR of 12.7% during 2025-2032. The surging demand for automated guest service solutions, the persistent labor shortages in hotels and restaurants, and advancements in AI-powered navigation and collaborative robot technologies

All 5 Releases


More Releases for Insulin

Insulin Delivery System Advancement Drives the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR This
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Advancing Insulin Delivery Systems boost the Global Insulin Path Pumps Market
Inkwood Research expects the Global Insulin Patch Pumps Market to surge with a 10.63% CAGR by 2032, and is set to generate $2760.98 million during the forecast period 2023-2032. Browse 50 market data Tables and 47 Figures spread over 173 Pages, along with an in-depth analysis of the Global Insulin Patch Pumps Market by Type, Delivery Mode, Disease Indication, Distribution Channel, & by Geography. Refer to the Report Summary Here: https://inkwoodresearch.com/reports/insulin-patch-pumps-market/#report-summary This insightful
Insulin Pumps Market Share, Trends and Growth Analysis By Type (Traditional Insu …
Insulin Pumps Market is expected to register a CAGR of 15.5% and acquire the market value of USD 11.5 Billion by 2028 during forecast period 2023-2032. Insulin pumps are discreet, electronic medical devices that can be tucked beneath clothing or fastened to a belt. In order to regulate the rise in blood glucose levels, the pump is used to deliver controlled quantities of insulin within the body at regular intervals
Insulin Patch Pumps Market Report 2018: Segmentation by Insulin Type (Bolus Insu …
Global Insulin Patch Pumps market research report provides company profile for Roche Holding AG, Cellnovo Group SA, Spring Health Solution Ltd., Debiotech, CeQur SA, Valeritas, Becton Dickenson & Company, Insulet Corporation, Johnson & Johnson, Medtrum Technologies Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue,
Insulin pump Market Explore Future Growth 2018-2026 by Global Type-Traditional i …
Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin